MERIT-NHL as an addendum to the International Registry of Radioimmunotherapy (RIT registry) pooling clinical data of patients who suffered from a non-Hodgkin´s lymphoma also includes the documentation of the respective FDG-PET and CT-image files in an online archive. Based on these documented clinical and imaging data, the MERIT study group centrally performs an intra- as well as interindividual evaluation of follicular CD20+ lymphoma lesions before and after radioimmunotherapy. According to this, the aim of the MERIT-NHL study is to prospectively identify yet unknown patient- and lesion specific prognostic factors predicting patient´s outcome in line with the therapeutic modality radioimmunotherapy.
Study Type
OBSERVATIONAL
Enrollment
150
Dept. of Nuclear Medicine, Saarland University Hospital
Homburg (Saar), Saarland, Germany
RECRUITINGKlinikum Karlsruhe, Dept. of Nuclear Medicine
Karlsruhe, Germany
RECRUITINGUniversity Clinic Kiel-Luebeck
Lübeck, Germany
ACTIVE_NOT_RECRUITINGTechnical University, Dept. of Nuclear Medicine
Munich, Germany
RECRUITINGEvaluation of patient- and lesion specific prognostic factors of radioimmunotherapy
Time frame: 3 years
Detection of diagnostical relevance of FDG-PET- and CT-image data findings in staging and re-staging of follicular non-Hodgkin´s lymphoma as well as in documentation of patient´s outcome after standard radioimmunotherapy
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.